Search

everythinglearnresearchcommunity

for

Search:↓

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

The committee decided not to approve the drug due to low effectiveness and high risks.

Some drugs can cause temporary or permanent hair loss.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Further research is needed to develop effective cancer prevention strategies.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

New molecules can prevent cell death in hair follicles.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.